- Home
- LFMD vs MRVI Comparison
LFMD vs MRVI Comparison
Compare LFMD & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- MRVI
- Stock Information
- Founded
- LFMD 1994
- MRVI 2014
- Country
- LFMD United States
- MRVI United States
- Employees
- LFMD N/A
- MRVI N/A
- Industry
- LFMD Medical/Nursing Services
- MRVI Biotechnology: Pharmaceutical Preparations
- Sector
- LFMD Health Care
- MRVI Health Care
- Exchange
- LFMD Nasdaq
- MRVI Nasdaq
- Market Cap
- LFMD 306.7M
- MRVI 347.5M
- IPO Year
- LFMD N/A
- MRVI 2020
- Fundamental
- Price
- LFMD $5.32
- MRVI $2.10
- Analyst Decision
- LFMD Strong Buy
- MRVI Hold
- Analyst Count
- LFMD 7
- MRVI 10
- Target Price
- LFMD $11.57
- MRVI $7.59
- AVG Volume (30 Days)
- LFMD 1.4M
- MRVI 3.7M
- Earning Date
- LFMD 05-07-2025
- MRVI 05-07-2025
- Dividend Yield
- LFMD N/A
- MRVI N/A
- EPS Growth
- LFMD N/A
- MRVI N/A
- EPS
- LFMD N/A
- MRVI N/A
- Revenue
- LFMD $212,453,838.00
- MRVI $259,185,000.00
- Revenue This Year
- LFMD $29.08
- MRVI N/A
- Revenue Next Year
- LFMD $18.81
- MRVI $14.59
- P/E Ratio
- LFMD N/A
- MRVI N/A
- Revenue Growth
- LFMD 39.27
- MRVI N/A
- 52 Week Low
- LFMD $3.99
- MRVI $2.07
- 52 Week High
- LFMD $12.88
- MRVI $11.56
- Technical
- Relative Strength Index (RSI)
- LFMD 45.04
- MRVI 28.24
- Support Level
- LFMD $5.14
- MRVI $2.09
- Resistance Level
- LFMD $5.64
- MRVI $2.26
- Average True Range (ATR)
- LFMD 0.34
- MRVI 0.19
- MACD
- LFMD -0.02
- MRVI 0.05
- Stochastic Oscillator
- LFMD 22.43
- MRVI 4.69
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.